Earnings Preview For TRACON Pharma
Portfolio Pulse from Benzinga Insights
TRACON Pharma (NASDAQ:TCON) is set to release its latest quarterly earnings report on November 9, 2023. Analysts estimate an earnings per share (EPS) of $-0.10. The company's past performance shows a trend of beating EPS estimates but experiencing a drop in share price the following day. The stock is currently trading at $0.15, down 89.97% over the last 52-week period.
November 08, 2023 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
TRACON Pharma is expected to report an EPS of $-0.10. Despite beating EPS estimates in the past, the company's share price has typically dropped the following day. The stock is currently down 89.97% over the last 52 weeks.
TRACON Pharma has a history of beating EPS estimates but experiencing a drop in share price the following day. Given this trend and the current negative returns, the upcoming earnings report could potentially lead to a further decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100